Craig A. Swandal's most recent trade in Apyx Medical Corp was a trade of 17,000 Stock Option (Option to Buy) done . Disclosure was reported to the exchange on Aug. 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apyx Medical Corp | Craig A. Swandal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2024 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 17,000 | 0 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.98 per share. | 21 Mar 2022 | 17,000 | 17,000 (0%) | 0% | 5.0 | 84,660 | Common Stock |
| Apyx Medical Corp | Craig A. Swandal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.42 per share. | 07 Jan 2022 | 7,173 | 60,173 (0%) | 0% | 9.4 | 67,570 | Common Stock |
| Apyx Medical Corp | Craig A. Swandal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 7,173 | 0 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) | |
| Apyx Medical Corp | Craig A. Swandal | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 17,000 | 17,000 | - | - | Stock Option (Option to Buy) |